Peter was diagnosed with cancer at the age of 12. Under pressure to deliver fast help, researchers in Heidelberg searched for a drug for him - with the help of mini-tumours grown in the laboratory.

After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year on the market. | After repeatedly wowing investors, Roche’s star eye med ...

SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

After the U.S. Supreme Court rejected the final appeal of a South Carolina inmate, he decided not to ask the governor for ...

The organization that runs a supervised injection site in Moncton says its work is saving lives and it’s unfortunate P.E.I.

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...

Roche Holding expects sales and core earnings to keep growing this year after beating analysts' expectations for 2024. The Swiss pharmaceutical giant is forecasting sales growth in the ...

Do you want us to inject Botox into your masseter muscle?” the dentist asked. My brows furrowed, as this is a question I expect at the dermatologist’s office, not the dentist's. However, injecting a ...